WallStreetZenWallStreetZen

NASDAQ: ICUI
Icu Medical Inc Stock Forecast, Predictions & Price Target

Analyst price target for ICUI

Based on 2 analysts offering 12 month price targets for Icu Medical Inc.
Min Forecast
$110.00+6.91%
Avg Forecast
$123.00+19.55%
Max Forecast
$136.00+32.18%

Should I buy or sell ICUI stock?

Based on 2 analysts offering ratings for Icu Medical Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ICUI stock forecasts and price targets.

ICUI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-28
lockedlocked$00.00+00.00%2023-12-14

1 of 1

Forecast return on equity

Is ICUI forecast to generate an efficient return?
Company
N/A
Industry
12.76%
Market
29.39%

Forecast return on assets

Is ICUI forecast to generate an efficient return on assets?
Company
N/A
Industry
7.28%

ICUI revenue forecast

What is ICUI's revenue in the next 2 years based on estimates from 3 analysts?
Avg 1 year Forecast
$2.3B+0.71%
Avg 2 year Forecast
$2.4B+4.94%
ICUI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ICUI revenue growth forecast

How is ICUI forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
0.71%
Industry
6.16%
Market
13.87%
ICUI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ICUI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ICUI vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
ICUI$102.89$123.00+19.55%Strong Buy
STAA$37.70$42.40+12.47%Buy
AZTA$59.43$74.67+25.64%Buy
WRBY$13.25$17.25+30.19%Buy
LMAT$67.20$64.50-4.02%Buy

Icu Medical Stock Forecast FAQ

Is Icu Medical Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ICUI) stock is to Strong Buy ICUI stock.

Out of 2 analysts, 1 (50%) are recommending ICUI as a Strong Buy, 1 (50%) are recommending ICUI as a Buy, 0 (0%) are recommending ICUI as a Hold, 0 (0%) are recommending ICUI as a Sell, and 0 (0%) are recommending ICUI as a Strong Sell.

If you're new to stock investing, here's how to buy Icu Medical stock.

What is ICUI's revenue growth forecast for 2024-2025?

(NASDAQ: ICUI) Icu Medical's forecast annual revenue growth rate of 0.71% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.87%.

Icu Medical's revenue in 2024 is $2,259,126,000.On average, 3 Wall Street analysts forecast ICUI's revenue for 2024 to be $54,928,340,766, with the lowest ICUI revenue forecast at $54,851,905,408, and the highest ICUI revenue forecast at $54,975,032,484.

In 2025, ICUI is forecast to generate $57,233,955,628 in revenue, with the lowest revenue forecast at $56,978,865,296 and the highest revenue forecast at $57,604,157,704.

What is ICUI's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: ICUI) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 7.28%.

What is ICUI's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ICUI price target, the average ICUI price target is $123.00, with the highest ICUI stock price forecast at $136.00 and the lowest ICUI stock price forecast at $110.00.

On average, Wall Street analysts predict that Icu Medical's share price could reach $123.00 by Feb 28, 2025. The average Icu Medical stock price prediction forecasts a potential upside of 19.55% from the current ICUI share price of $102.89.

What is ICUI's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: ICUI) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.